Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [BUSINESS]
3 clusters · 9 sources · 30 days · First seen · Last updated
Evonik corporate expansion and strategic growth
Overview
Evonik has initiated a multi-faceted growth strategy focused on sustainability and pharmaceutical manufacturing. The company aims to generate €1.5 billion in additional revenue by 2032 through innovations in biotechnology, the energy transition, and the circular economy. This includes developing renewable biosurfactants and carbon capture technologies.
In the pharmaceutical sector, Evonik is investing over CAD 150 million to expand operations in Vancouver, Canada, to produce lipid-based drug delivery systems, such as lipid nanoparticles used in mRNA vaccines. This is complemented by a new lipid manufacturing site in Lafayette, Indiana.
Furthering its industrial capacity, the company has invested €52 million to expand its silicone platform at the Essen Goldschmidtstrasse site in Germany. This expansion involves constructing a new production plant and tank farm to increase capacity for organomodified silicones used in automotive, insulation, and personal care sectors. The project included expanding the site area from 32 to 35 hectares and installing a 150-meter pipe bridge to connect four production units and 15 manufacturing assets. According to company officials, the investment is intended to strengthen supply chain resilience, optimize logistics, and reduce the need to transport intermediates between sites.
During its Q3 2026 earnings call, the company also introduced a new executive board setup under Interim CEO Claus Rettig, who previously led the Asia region.
Entities
Essen · Evonik · Vancouver · Claus Rettig · BASF
Timeline
-
[BUSINESS] 7 sourcesEvonik invests 52 million euros in German silicone capacity
Evonik has invested 52 million euros to expand its silicone production capacity and logistics infrastructure at its Essen site in Germany.
-
[BUSINESS] 3 sourcesEvonik invests €52 million to expand silicone production in Germany
Evonik is investing €52 million to expand its silicone production capacity at its Essen, Germany site to bolster its global supply chain and serve diverse industrial markets.
-
[BUSINESS] 2 sourcesEvonik targets €1.5 billion in revenue through sustainability and pharmaceutical expansion
Evonik is targeting €1.5 billion in new revenue by 2032 through sustainability initiatives and investing over CAD 150 million to expand lipid nanoparticle production in Vancouver, Canada.
Sources
ad-hoc-news.de · chemengonline.com · farbeundlack.de · kurierverlag.de · rubberjournalasia.com · saarbruecker-zeitung.de · seekingalpha.com · thebusinesstimes.co.uk · volksfreund.de
This summary has been updated 1 time: see revision history